PDB Short entry for 1SUQ HEADER TRANSFERASE 26-MAR-04 1SUQ TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TITLE 2 JANSSEN-R185545 CAVEAT 1SUQ CHIRALITY ERROR AT ILE A 31 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66 SUBUNIT; COMPND 5 SYNONYM: HIV-1 RT; COMPND 6 EC: 2.7.7.49; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: REVERSE TRANSCRIPTASE; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: P51 SUBUNIT; COMPND 13 SYNONYM: HIV-1 RT; COMPND 14 EC: 2.7.7.49; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: BH10 ISOLATE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 9 ORGANISM_TAXID: 11676; SOURCE 10 STRAIN: BH10 ISOLATE; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AIDS, HIV, DRUG DESIGN, REVERSE TRANSCRIPTASE, RT, PROTEIN-INHIBITOR KEYWDS 2 COMPLEX, DRUG RESISTANCE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.DAS,E.ARNOLD REVDAT 4 27-OCT-21 1SUQ 1 REMARK SEQADV SHEET LINK REVDAT 3 24-FEB-09 1SUQ 1 VERSN REVDAT 2 15-JUN-04 1SUQ 1 REMARK REVDAT 1 11-MAY-04 1SUQ 0 JRNL AUTH K.DAS,A.D.CLARK JR.,P.J.LEWI,J.HEERES,M.R.DE JONGE, JRNL AUTH 2 L.M.KOYMANS,H.M.VINKERS,F.DAEYAERT,D.W.LUDOVICI,M.J.KUKLA, JRNL AUTH 3 B.DE CORTE,R.W.KAVASH,C.Y.HO,H.YE,M.A.LICHTENSTEIN, JRNL AUTH 4 K.ANDRIES,R.PAUWLES,M.-P.DEBETHUNE,P.L.BOYER,P.CLARK, JRNL AUTH 5 S.H.HUGHES,P.A.JANSSEN,E.ARNOLD JRNL TITL ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN JRNL TITL 2 STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE) AND JRNL TITL 3 RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT JRNL TITL 4 ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND JRNL TITL 5 DRUG-RESISTANT HIV-1 VARIANTS JRNL REF J.MED.CHEM. V. 47 2550 2004 JRNL REFN ISSN 0022-2623 JRNL PMID 15115397 JRNL DOI 10.1021/JM030558S REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.DING,K.DAS,H.MOEREELS,L.KOYMANS,K.ANDRIES,P.A.JANSSEN, REMARK 1 AUTH 2 S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 RT/TIBO R 86183 COMPLEX REVEALS REMARK 1 TITL 2 SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE REMARK 1 TITL 3 INHIBITORS REMARK 1 REF NAT.STRUCT.BIOL. V. 2 407 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 7545077 REMARK 1 DOI 10.1038/NSB0595-407 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.DING,K.DAS,C.TANTILLO,W.ZHANG,A.D.CLARK JR.,S.JESSEN,X.LU, REMARK 1 AUTH 2 Y.HSIOU,A.JACOBO-MOLINA,K.ANDRIES,R.PAUWELS,H.MOEREELS, REMARK 1 AUTH 3 L.KOYMANS,P.A.J.JANSSEN,R.H.SMITH JR.,M.KROEGER KOEPKE, REMARK 1 AUTH 4 C.J.MICHEJDA,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH REMARK 1 TITL 2 THE NON-NUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 A REMARK 1 TITL 3 RESOLUTION REMARK 1 REF STRUCTURE V. 3 365 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 7542140 REMARK 1 DOI 10.1016/S0969-2126(01)00168-X REMARK 1 REFERENCE 3 REMARK 1 AUTH K.DAS,J.DING,Y.HSIOU,A.D.CLARK JR.,H.MOEREELS,L.KOYMANS, REMARK 1 AUTH 2 K.ANDRIES,R.PAUWELS,P.A.JANSSEN,P.L.BOYER,P.CLARK, REMARK 1 AUTH 3 R.H.SMITH JR.,M.B.KROEGER SMITH,C.J.MICHEJDA,S.H.HUGHES, REMARK 1 AUTH 4 E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURES OF 8-CL AND 9-CL TIBO COMPLEXED WITH REMARK 1 TITL 2 WILD-TYPE HIV-1 RT AND 8-CL TIBO COMPLEXED WITH THE REMARK 1 TITL 3 TYR181CYS HIV-1 RT DRUG-RESISTANT MUTANT REMARK 1 REF J.MOL.BIOL. V. 264 1085 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9000632 REMARK 1 DOI 10.1006/JMBI.1996.0698 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.DING,K.DAS,Y.HSIOU,S.G.SARAFIANOS,A.D.CLARK JR., REMARK 1 AUTH 2 A.JACOBO-MOLINA,C.TANTILLO,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE AND FUNCTIONAL IMPLICATIONS OF THE POLYMERASE REMARK 1 TITL 2 ACTIVE SITE REGION IN A COMPLEX OF HIV-1 RT WITH A REMARK 1 TITL 3 DOUBLE-STRANDED DNA TEMPLATE-PRIMER AND AN ANTIBODY FAB REMARK 1 TITL 4 FRAGMENT AT 2.8 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 284 1095 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9837729 REMARK 1 DOI 10.1006/JMBI.1998.2208 REMARK 1 REFERENCE 5 REMARK 1 AUTH D.W.LUDOVICI,B.L.DE CORTE,M.J.KUKLA,H.YE,C.Y.HO, REMARK 1 AUTH 2 M.A.LICHTENSTEIN,R.W.KAVASH,K.ANDRIES,M.P.DE BETHUNE, REMARK 1 AUTH 3 H.AZIJN,R.PAUWELS,P.J.LEWI,J.HEERES,L.M.KOYMANS, REMARK 1 AUTH 4 M.R.DE JONGE,K.J.VAN AKEN,F.F.DAEYAERT,K.DAS,E.ARNOLD, REMARK 1 AUTH 5 P.A.JANSSEN REMARK 1 TITL EVOLUTION OF ANTI-HIV DRUG CANDIDATES. PART 3: REMARK 1 TITL 2 DIARYLPYRIMIDINE (DAPY) ANALOGUES REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 11 2235 2001 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 11527705 REMARK 1 DOI 10.1016/S0960-894X(01)00412-7 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 386514.050 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 28520 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.262 REMARK 3 FREE R VALUE : 0.325 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1404 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 67.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3296 REMARK 3 BIN R VALUE (WORKING SET) : 0.4290 REMARK 3 BIN FREE R VALUE : 0.4620 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 183 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8023 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 84.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 24.66000 REMARK 3 B22 (A**2) : -18.67000 REMARK 3 B33 (A**2) : -5.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 34.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM SIGMAA (A) : 0.85 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.61 REMARK 3 ESD FROM C-V SIGMAA (A) : 1.02 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.260 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.470 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.110 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.130 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.990 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.20 REMARK 3 BSOL : 10.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 185.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : 185.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SUQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-APR-04. REMARK 100 THE DEPOSITION ID IS D_1000022006. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29837 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.41500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 1.0 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.80 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 113.05500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.73500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 113.05500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.73500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 49120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 553 REMARK 465 ALA A 554 REMARK 465 GLY A 555 REMARK 465 ILE A 556 REMARK 465 ARG A 557 REMARK 465 LYS A 558 REMARK 465 ILE A 559 REMARK 465 LEU A 560 REMARK 465 GLN B 428 REMARK 465 LEU B 429 REMARK 465 GLU B 430 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 31 CD1 REMARK 470 ILE B 270 CG1 CG2 CD1 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLU A 546 REMARK 475 GLN A 547 REMARK 475 VAL A 548 REMARK 475 ASP A 549 REMARK 475 LYS A 550 REMARK 475 LEU A 551 REMARK 475 VAL A 552 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LEU A 26 CG CD1 CD2 REMARK 480 ASN A 54 CG OD1 ND2 REMARK 480 PHE A 61 CG CD1 CD2 CE1 CE2 CZ REMARK 480 ILE A 63 CG1 CG2 CD1 REMARK 480 LYS A 66 CG CD CE NZ REMARK 480 GLU A 89 CG CD OE1 OE2 REMARK 480 LEU A 92 CG CD1 CD2 REMARK 480 ASP A 113 CG OD1 OD2 REMARK 480 ASN A 137 CG OD1 ND2 REMARK 480 ILE A 142 CG1 CG2 CD1 REMARK 480 ASP A 177 CG OD1 OD2 REMARK 480 LYS A 220 CG CD CE NZ REMARK 480 HIS A 221 CG ND1 CD2 CE1 NE2 REMARK 480 LYS A 223 CG REMARK 480 GLU A 297 CG CD OE1 OE2 REMARK 480 GLU A 396 CG CD OE1 OE2 REMARK 480 LYS A 451 CG CD CE NZ REMARK 480 LYS A 512 CG CD CE NZ REMARK 480 LYS B 65 CG CD CE NZ REMARK 480 LYS B 66 CG CD CE NZ REMARK 480 ASP B 67 CG OD1 OD2 REMARK 480 LYS B 70 CG CD CE NZ REMARK 480 LYS B 219 CG CD CE NZ REMARK 480 LYS B 220 CG CD CE NZ REMARK 480 LEU B 228 CG CD1 CD2 REMARK 480 TRP B 229 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 480 TRP B 229 CZ3 CH2 REMARK 480 MET B 230 CG SD CE REMARK 480 LYS B 238 CG CD CE NZ REMARK 480 GLN B 242 CG CD OE1 NE2 REMARK 480 ILE B 244 CG1 CG2 CD1 REMARK 480 LYS B 275 CG CD CE NZ REMARK 480 LYS B 353 CG CD CE NZ REMARK 480 ASN B 418 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG B 125 N TYR B 127 2.11 REMARK 500 OH TYR B 115 O MET B 184 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 14 C - N - CA ANGL. DEV. = 9.5 DEGREES REMARK 500 PRO A 14 C - N - CD ANGL. DEV. = -12.9 DEGREES REMARK 500 PRO A 225 C - N - CA ANGL. DEV. = 13.5 DEGREES REMARK 500 PRO A 225 C - N - CD ANGL. DEV. = -19.4 DEGREES REMARK 500 PRO A 226 C - N - CA ANGL. DEV. = 24.0 DEGREES REMARK 500 PRO A 226 C - N - CD ANGL. DEV. = -21.3 DEGREES REMARK 500 PRO A 236 C - N - CA ANGL. DEV. = 9.5 DEGREES REMARK 500 PRO A 272 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 PRO A 345 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 PRO A 412 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 PRO B 95 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 PRO B 97 C - N - CA ANGL. DEV. = 10.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 37.73 -91.65 REMARK 500 LYS A 13 153.84 -43.72 REMARK 500 PRO A 14 -73.03 -16.01 REMARK 500 MET A 16 170.53 -42.63 REMARK 500 GLU A 28 -58.45 -28.34 REMARK 500 GLU A 36 -71.28 -72.27 REMARK 500 PRO A 52 105.72 -46.72 REMARK 500 GLU A 53 92.06 -176.99 REMARK 500 ASN A 54 -10.20 77.37 REMARK 500 PRO A 55 165.84 -49.93 REMARK 500 LYS A 64 105.46 -161.20 REMARK 500 LYS A 65 -126.40 -83.81 REMARK 500 LYS A 82 -3.32 -51.00 REMARK 500 ALA A 98 -11.75 -47.97 REMARK 500 LYS A 104 -79.97 -79.14 REMARK 500 ASP A 113 -15.36 -49.42 REMARK 500 ALA A 114 -95.09 -37.91 REMARK 500 TYR A 115 -20.51 -38.10 REMARK 500 ASP A 121 97.25 -36.95 REMARK 500 GLU A 122 -48.68 -16.56 REMARK 500 SER A 134 -103.18 -93.29 REMARK 500 ASN A 137 12.40 -64.15 REMARK 500 PRO A 140 86.32 -46.44 REMARK 500 TRP A 153 148.27 -37.93 REMARK 500 ALA A 158 -74.27 -63.45 REMARK 500 ILE A 159 -11.94 -48.15 REMARK 500 PHE A 160 -71.56 -87.20 REMARK 500 SER A 162 -82.57 -66.43 REMARK 500 SER A 163 -45.21 -29.63 REMARK 500 MET A 164 -79.61 -52.90 REMARK 500 THR A 165 -44.28 -29.59 REMARK 500 GLU A 169 -61.43 -24.25 REMARK 500 GLN A 174 3.35 -65.36 REMARK 500 ASN A 175 49.69 -142.34 REMARK 500 PRO A 176 0.13 -53.42 REMARK 500 MET A 184 -121.29 72.62 REMARK 500 LEU A 187 89.39 -154.22 REMARK 500 ILE A 195 -19.35 -31.63 REMARK 500 THR A 200 -71.11 -86.32 REMARK 500 TRP A 212 31.52 -84.01 REMARK 500 GLN A 222 -146.78 -145.30 REMARK 500 GLU A 224 -165.12 -125.18 REMARK 500 PRO A 225 86.17 -37.83 REMARK 500 MET A 230 102.02 -49.53 REMARK 500 ASP A 237 14.59 -146.94 REMARK 500 THR A 240 178.75 178.25 REMARK 500 LYS A 259 -18.77 -46.27 REMARK 500 ILE A 270 -17.80 -141.10 REMARK 500 PRO A 272 -61.23 -15.52 REMARK 500 ILE A 274 122.37 -31.49 REMARK 500 REMARK 500 THIS ENTRY HAS 146 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 PHE B 130 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 601 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD2 REMARK 620 2 ASP A 443 OD1 57.4 REMARK 620 3 ASP A 498 OD1 142.0 88.1 REMARK 620 4 ASN A 545 OD1 86.3 135.3 131.6 REMARK 620 N 1 2 3 REMARK 700 REMARK 700 SHEET REMARK 700 SHEET DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 185 A 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1S6Q RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN REMARK 900 COMPLEX WITH JANSSEN-R147681 REMARK 900 RELATED ID: 1S9E RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN REMARK 900 COMPLEX WITH JANSSEN-R129385 REMARK 900 RELATED ID: 1S9G RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN REMARK 900 COMPLEX WITH JANSSEN-R120394 REMARK 900 RELATED ID: 1S6P RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943 REMARK 900 RELATED ID: 1SV5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN REMARK 900 COMPLEX WITH JANSSEN-R165335 REMARK 900 RELATED ID: 1HNV RELATED DB: PDB REMARK 900 THE STRUCTURE OF HIV-1 RT/TIBO R 86183 COMPLEX REMARK 900 RELATED ID: 1HNI RELATED DB: PDB REMARK 900 THE STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE REMARK 900 NON-NUCLEOSIDE INHIBITOR ALPHA-APA R 95845 REMARK 900 RELATED ID: 2HMI RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE -STRANDED DNA REMARK 900 AND FAB28 DBREF 1SUQ A 1 560 UNP P03366 POL_HV1B1 168 727 DBREF 1SUQ B 1 430 UNP P03366 POL_HV1B1 168 597 SEQADV 1SUQ SER A 280 UNP P03366 CYS 447 ENGINEERED MUTATION SEQADV 1SUQ SER B 280 UNP P03366 CYS 447 ENGINEERED MUTATION SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 560 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 560 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 560 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 560 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 560 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 560 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 560 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 560 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 560 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE SEQRES 44 A 560 LEU SEQRES 1 B 430 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 430 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 430 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 430 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 430 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 430 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 430 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 430 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 430 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 430 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 430 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 430 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 430 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 430 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 430 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 430 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 430 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 430 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 430 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 430 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 430 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 430 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 430 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 430 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 430 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 430 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 430 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 430 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 430 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 430 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 430 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 430 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 430 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 430 GLU HET MG A 601 1 HET 185 A 600 29 HETNAM MG MAGNESIUM ION HETNAM 185 (6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4- HETNAM 2 185 (AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL) HETNAM 3 185 METHANOL FORMUL 3 MG MG 2+ FORMUL 4 185 C21 H16 BR N5 O2 HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 LYS A 82 1 6 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ASP A 113 SER A 117 5 5 HELIX 5 5 ASP A 121 ASP A 123 5 3 HELIX 6 6 PHE A 124 ALA A 129 1 6 HELIX 7 7 GLY A 155 GLN A 174 1 20 HELIX 8 8 GLU A 194 TRP A 212 1 19 HELIX 9 9 THR A 253 GLN A 269 1 17 HELIX 10 10 VAL A 276 LEU A 282 1 7 HELIX 11 11 GLU A 297 LYS A 311 1 15 HELIX 12 12 ASN A 363 TRP A 383 1 21 HELIX 13 13 GLN A 394 TYR A 405 1 12 HELIX 14 14 THR A 473 SER A 489 1 17 HELIX 15 15 SER A 499 ALA A 508 1 10 HELIX 16 16 SER A 515 LYS A 528 1 14 HELIX 17 17 ASN A 545 LYS A 550 1 6 HELIX 18 18 THR B 27 GLU B 44 1 18 HELIX 19 19 PHE B 77 THR B 84 1 8 HELIX 20 20 GLN B 85 TRP B 88 5 4 HELIX 21 21 ASP B 113 VAL B 118 5 6 HELIX 22 22 PHE B 124 TYR B 127 5 4 HELIX 23 23 SER B 134 GLU B 138 5 5 HELIX 24 24 GLY B 155 GLU B 169 1 15 HELIX 25 25 GLU B 194 ARG B 211 1 18 HELIX 26 26 HIS B 235 TRP B 239 5 5 HELIX 27 27 THR B 253 SER B 268 1 16 HELIX 28 28 GLU B 298 GLU B 312 1 15 HELIX 29 29 ASN B 363 GLY B 384 1 22 HELIX 30 30 GLN B 394 TRP B 402 1 9 HELIX 31 31 THR B 403 TRP B 406 5 4 HELIX 32 32 LEU B 422 TYR B 427 1 6 SHEET 1 A 3 ILE A 47 ILE A 50 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 SHEET 3 A 3 THR A 128 ILE A 132 -1 SHEET 1 C 3 SER A 105 VAL A 111 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 SHEET 3 C 3 ILE A 178 TYR A 183 -1 SHEET 1 D 2 PHE A 227 TRP A 229 0 SHEET 2 D 2 LYS A 238 THR A 240 -1 SHEET 1 E 4 LYS A 347 ALA A 355 0 SHEET 2 E 4 GLN A 336 TYR A 342 -1 SHEET 3 E 4 LEU A 325 GLN A 332 -1 SHEET 4 E 4 GLU A 413 THR A 419 1 SHEET 1 F 2 HIS A 361 THR A 362 0 SHEET 2 F 2 LYS A 512 SER A 513 -1 SHEET 1 G 4 LEU A 452 THR A 459 0 SHEET 2 G 4 GLU A 438 ASN A 447 -1 SHEET 3 G 4 GLU A 492 THR A 497 1 SHEET 4 G 4 LYS A 530 VAL A 536 1 SHEET 1 H 2 ILE B 142 TYR B 146 0 SHEET 2 H 2 ALA B 129 ILE B 132 -1 SHEET 1 J 3 ASP B 186 SER B 191 0 SHEET 2 J 3 SER B 105 ASP B 110 0 SHEET 3 J 3 GLU B 233 LEU B 234 -1 SHEET 1 K 4 ASN B 348 ALA B 355 0 SHEET 2 K 4 GLN B 336 TYR B 342 -1 SHEET 3 K 4 ILE B 326 LYS B 331 -1 SHEET 4 K 4 GLU B 413 VAL B 417 1 LINK OD2 ASP A 443 MG MG A 601 1555 1555 2.46 LINK OD1 ASP A 443 MG MG A 601 1555 1555 2.10 LINK OD1 ASP A 498 MG MG A 601 1555 1555 2.28 LINK OD1 ASN A 545 MG MG A 601 1555 1555 2.15 CISPEP 1 PRO A 225 PRO A 226 0 2.27 CISPEP 2 PRO A 420 PRO A 421 0 -0.46 SITE 1 AC1 3 ASP A 443 ASP A 498 ASN A 545 SITE 1 AC2 12 LEU A 100 LYS A 101 LYS A 103 VAL A 106 SITE 2 AC2 12 VAL A 179 TYR A 188 GLY A 190 PHE A 227 SITE 3 AC2 12 LEU A 234 HIS A 235 PRO A 236 TYR A 318 CRYST1 226.110 69.470 104.260 90.00 106.82 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004423 0.000000 0.001337 0.00000 SCALE2 0.000000 0.014395 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010020 0.00000